Skip to Content
Merck
  • Vitrification of human embryos subjected to blastomere biopsy for pre-implantation genetic screening produces higher survival and pregnancy rates than slow freezing.

Vitrification of human embryos subjected to blastomere biopsy for pre-implantation genetic screening produces higher survival and pregnancy rates than slow freezing.

Journal of assisted reproduction and genetics (2009-12-08)
Levent Keskintepe, Geoffrey Sher, Anna Machnicka, Drew Tortoriello, Aykut Bayrak, Jeffrey Fisch, Yuksel Agca
ABSTRACT

Cryopreservation of blastocysts, especially those subjected to the trauma due to blastomere biopsy for the purposes of pre-implantation genetic screening (PGS), requires significant optimization. Laboratory and clinical outcomes were compared to determine the effect of two different cryopreservation techniques on the development of human pre-implantation embryos that underwent blastomere biopsy and blastocoel drainage prior to cryopreservation. Retrospective clinical study. Women who requested cryotransfer of supernumerary blastocysts were analyzed by FISH. The main outcome measures were post-thaw survival (SR), pregnancy (PR), and implantation (IR). The SR of slowly frozen blastocysts was 83% compared to 97% for vitrified blastocysts. In 160 cases where biopsied embryos were cryotransferred, the results for slowly frozen versus vitrified blastocysts were: SR (71% vs. 95%), PR (23% vs. 37%), and IR (26% vs. 36%, P < 0.05), respectively. The results revealed that vitrified blastocysts provided higher SR, PR and IR as compared to slowly frozen counterparts.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Dimethyl sulfoxide, ReagentPlus®, ≥99.5%